Annual CFF
$0.00
-$734.00 K-100.00%
31 December 2023
Summary:
Vanda Pharmaceuticals annual cash flow from financing activities is currently $0.00, with the most recent change of -$734.00 thousand (-100.00%) on 31 December 2023. During the last 3 years, it has fallen by -$5.63 million (-100.00%). VNDA annual CFF is now -100.00% below its all-time high of $111.40 million, reached on 31 December 2007.VNDA Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
N/A
30 September 2024
Summary:
Vanda Pharmaceuticals quarterly cash flow from financing activities is not available.VNDA Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
N/A
30 September 2024
Summary:
Vanda Pharmaceuticals TTM cash flow from financing activities is not available.VNDA TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VNDA Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | - | - |
| 3 y3 years | -100.0% | - | - |
| 5 y5 years | -100.0% | - | - |
VNDA Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -100.0% | |||||
| 5 y | 5 years | -100.0% | |||||
| alltime | all time | -100.0% |
Vanda Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $0.00(-100.0%) | - | - |
| Dec 2022 | $734.00 K(-79.3%) | $605.00 K(>+9900.0%) | $734.00 K(-37.3%) |
| Sept 2022 | - | $4000.00(-96.8%) | $1.17 M(-23.9%) |
| June 2022 | - | $125.00 K(-88.0%) | $1.54 M(-56.7%) |
| Dec 2021 | $3.55 M(-37.0%) | $1.04 M(+180.6%) | $3.55 M(-9.9%) |
| Sept 2021 | - | $371.00 K(+28.4%) | $3.94 M(+6.7%) |
| June 2021 | - | $289.00 K(-84.4%) | $3.69 M(-47.3%) |
| Mar 2021 | - | $1.85 M(+29.1%) | $7.00 M(+24.3%) |
| Dec 2020 | $5.63 M(-10.1%) | $1.43 M(+1064.2%) | $5.63 M(-10.8%) |
| Sept 2020 | - | $123.00 K(-96.6%) | $6.32 M(-6.4%) |
| June 2020 | - | $3.60 M(+651.6%) | $6.75 M(+2.9%) |
| Mar 2020 | - | $479.00 K(-77.4%) | $6.56 M(+4.8%) |
| Dec 2019 | $6.26 M(-94.2%) | $2.12 M(+279.2%) | $6.26 M(+26.8%) |
| Sept 2019 | - | $558.00 K(-83.6%) | $4.94 M(+9.9%) |
| June 2019 | - | $3.41 M(+1805.6%) | $4.49 M(+25.8%) |
| Mar 2019 | - | $179.00 K(-77.4%) | $3.57 M(-96.7%) |
| Dec 2018 | $107.13 M(+1940.1%) | $792.00 K(+607.1%) | $107.13 M(+0.7%) |
| Sept 2018 | - | $112.00 K(-95.5%) | $106.42 M(-0.6%) |
| June 2018 | - | $2.49 M(-97.6%) | $107.07 M(+0.3%) |
| Mar 2018 | - | $103.73 M(>+9900.0%) | $106.78 M(+1933.4%) |
| Dec 2017 | $5.25 M(-32.3%) | $81.00 K(-89.5%) | $5.25 M(-11.3%) |
| Sept 2017 | - | $768.00 K(-65.0%) | $5.92 M(-46.7%) |
| June 2017 | - | $2.19 M(-0.7%) | $11.11 M(+11.9%) |
| Mar 2017 | - | $2.21 M(+194.5%) | $9.94 M(+28.2%) |
| Dec 2016 | $7.75 M(+89.5%) | $750.00 K(-87.4%) | $7.75 M(+10.7%) |
| Sept 2016 | - | $5.96 M(+487.4%) | $7.00 M(+51.6%) |
| June 2016 | - | $1.01 M(+4129.2%) | $4.62 M(+10.1%) |
| Mar 2016 | - | $24.00 K(-2500.0%) | $4.19 M(+2.5%) |
| Dec 2015 | $4.09 M(-95.4%) | -$1000.00(-100.0%) | $4.09 M(-95.5%) |
| Sept 2015 | - | $3.58 M(+504.6%) | $91.58 M(+3.8%) |
| June 2015 | - | $592.00 K(-849.4%) | $88.20 M(+0.6%) |
| Mar 2015 | - | -$79.00 K(-100.1%) | $87.64 M(-2.3%) |
| Dec 2014 | $89.73 M(+80.0%) | $87.49 M(>+9900.0%) | $89.73 M(+3245.6%) |
| Sept 2014 | - | $198.00 K(+518.8%) | $2.68 M(-94.8%) |
| June 2014 | - | $32.00 K(-98.4%) | $51.30 M(-1.5%) |
| Mar 2014 | - | $2.01 M(+356.0%) | $52.06 M(+4.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2013 | $49.86 M(>+9900.0%) | $441.00 K(-99.1%) | $49.86 M(+0.9%) |
| Sept 2013 | - | $48.82 M(+6048.2%) | $49.43 M(+7963.6%) |
| June 2013 | - | $794.00 K(-511.4%) | $613.00 K(-438.7%) |
| Mar 2013 | - | -$193.00 K(-1708.3%) | -$181.00 K(-1608.3%) |
| Dec 2012 | $12.00 K(-52.0%) | $12.00 K(>+9900.0%) | $12.00 K(-40.0%) |
| Sept 2012 | - | $0.00(0.0%) | $20.00 K(-20.0%) |
| June 2012 | - | $0.00(0.0%) | $25.00 K(0.0%) |
| Mar 2012 | - | $0.00(-100.0%) | $25.00 K(0.0%) |
| Dec 2011 | $25.00 K(-99.3%) | $20.00 K(+300.0%) | $25.00 K(-98.2%) |
| Sept 2011 | - | $5000.00(>+9900.0%) | $1.35 M(-2.7%) |
| June 2011 | - | $0.00(0.0%) | $1.39 M(-25.0%) |
| Mar 2011 | - | $0.00(-100.0%) | $1.85 M(-51.1%) |
| Dec 2010 | $3.78 M(+133.7%) | $1.35 M(+3107.1%) | $3.78 M(+36.5%) |
| Sept 2010 | - | $42.00 K(-90.9%) | $2.77 M(-11.5%) |
| June 2010 | - | $462.00 K(-76.1%) | $3.13 M(-11.8%) |
| Mar 2010 | - | $1.93 M(+476.5%) | $3.55 M(+119.4%) |
| Dec 2009 | $1.62 M(>+9900.0%) | $335.30 K(-16.4%) | $1.62 M(+26.1%) |
| Sept 2009 | - | $400.90 K(-54.6%) | $1.28 M(+45.4%) |
| June 2009 | - | $882.80 K(>+9900.0%) | $882.80 K(>+9900.0%) |
| Mar 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2008 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sept 2008 | - | $0.00(0.0%) | $45.50 K(-34.2%) |
| June 2008 | - | $0.00(0.0%) | $69.10 K(+23.8%) |
| Mar 2008 | - | $0.00(-100.0%) | $55.80 K(-99.9%) |
| Dec 2007 | $111.40 M(+109.0%) | $45.50 K(+92.8%) | $111.40 M(-0.0%) |
| Sept 2007 | - | $23.60 K(-277.4%) | $111.44 M(+0.1%) |
| June 2007 | - | -$13.30 K(-100.0%) | $111.36 M(-32.4%) |
| Mar 2007 | - | $111.35 M(>+9900.0%) | $164.71 M(+208.9%) |
| Dec 2006 | $53.31 M(+60.1%) | $77.80 K(-260.1%) | $53.31 M(-21.8%) |
| Sept 2006 | - | -$48.60 K(-100.1%) | $68.20 M(-21.4%) |
| June 2006 | - | $53.33 M(<-9900.0%) | $86.71 M(+160.1%) |
| Mar 2006 | - | -$45.90 K(-100.3%) | $33.34 M(+0.1%) |
| Dec 2005 | $33.29 M(+83.5%) | $14.96 M(-19.0%) | $33.29 M(+81.6%) |
| Sept 2005 | - | $18.46 M(<-9900.0%) | $18.33 M(<-9900.0%) |
| June 2005 | - | -$39.50 K(-55.8%) | -$128.80 K(+44.2%) |
| Mar 2005 | - | -$89.30 K | -$89.30 K |
| Dec 2004 | $18.15 M | - | - |
FAQ
- What is Vanda Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Vanda Pharmaceuticals?
- What is Vanda Pharmaceuticals annual CFF year-on-year change?
- What is the all time high quarterly CFF for Vanda Pharmaceuticals?
- What is the all time high TTM CFF for Vanda Pharmaceuticals?
What is Vanda Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of VNDA is $0.00
What is the all time high annual CFF for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high annual cash flow from financing activities is $111.40 M
What is Vanda Pharmaceuticals annual CFF year-on-year change?
Over the past year, VNDA annual cash flow from financing activities has changed by -$734.00 K (-100.00%)
What is the all time high quarterly CFF for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high quarterly cash flow from financing activities is $111.35 M
What is the all time high TTM CFF for Vanda Pharmaceuticals?
Vanda Pharmaceuticals all-time high TTM cash flow from financing activities is $164.71 M